FDA Johnson & Johnson

News

FDA, Covid-19 and Vaccine

New FDA Covid-19 Policy Supports Vaccines for High-Risk Groups, More Clinical Trials for Others

In calling for more clinical testing of vaccines in younger people and those who face a low risk of severe disease from Covid-19, the FDA said its policy will compel generation of more evidence for these groups.

MedCity News · 1d

· 7d · on MSN

FDA Changes May Limit COVID Vaccine Access—Drawing Some Criticism. Here’s What We Know

· 2d · on MSN

FDA’s plan to limit covid vaccines worries some who won’t be eligible

3don MSN

US FDA Votes in Favor of Benefit-Risk Profile of Johnson & Johnson’s DARZALEX FASPRO

Johnson & Johnson (NYSE:JNJ) announced that the FDA Oncologic Drugs Advisory Committee/ODAC voted 6-2 in favor of the benefit ...

Did Johnson & Johnson put profit over safety? | The Excerpt

For generations of Americans the Johnson & Johnson brand has been a beloved one, as quintessentially American as baseball and ...

Fierce Pharma11d

Weighing approval bids from J&J, Pfizer and Roche, FDA scrutinizes data ahead of adcomm

One possible explanation for the gap is the availability of highly efficacious CAR-T therapies in the U.S. and Europe serving ...

J&J Says FDA Advisory Panel Favors Benefit-Risk Profile of Darzalex Faspro in Myeloma Treatment

The pharmaceutical company said Tuesday the FDA's Oncologic Drugs Advisory Committee voted 6-2 in favor of Darzalex Faspro, or daratumumab and hyaluronidase-fihj, to treat adult patients with ...

MassDevice8d

Johnson & Johnson hit with $147M antitrust verdict

A federal jury has ordered Johnson & Johnson's Biosense Webster business to pay $147 million to a cardiac mapping catheter reprocessor.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results